P3.01-90 A Phase II Study Evaluating Continuation of EGFR-TKIs Beyond Progressive Disease Followed by the Addition of CDDP+PEM+Bev
JOURNAL OF THORACIC ONCOLOGY（2018）
关键词
The phase II study,EGFR-TKIs,cisplatin pemetrexed bevacizumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要